These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. DNA microarray and signal transduction analysis in pulmonary artery smooth muscle cells from heritable and idiopathic pulmonary arterial hypertension subjects. Yu J; Wilson J; Taylor L; Polgar P J Cell Biochem; 2015 Mar; 116(3):386-97. PubMed ID: 25290246 [TBL] [Abstract][Full Text] [Related]
5. Crucial role of RAGE in inappropriate increase of smooth muscle cells from patients with pulmonary arterial hypertension. Nakamura K; Sakaguchi M; Matsubara H; Akagi S; Sarashina T; Ejiri K; Akazawa K; Kondo M; Nakagawa K; Yoshida M; Miyoshi T; Ogo T; Oto T; Toyooka S; Higashimoto Y; Fukami K; Ito H PLoS One; 2018; 13(9):e0203046. PubMed ID: 30180189 [TBL] [Abstract][Full Text] [Related]
6. Plasminogen activator inhibitor type 1 inhibits smooth muscle cell proliferation in pulmonary arterial hypertension. Kouri FM; Queisser MA; Königshoff M; Chrobak I; Preissner KT; Seeger W; Eickelberg O Int J Biochem Cell Biol; 2008; 40(9):1872-82. PubMed ID: 18337154 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of Excessive Cell Proliferation by Calcilytics in Idiopathic Pulmonary Arterial Hypertension. Yamamura A; Ohara N; Tsukamoto K PLoS One; 2015; 10(9):e0138384. PubMed ID: 26375676 [TBL] [Abstract][Full Text] [Related]
8. Involvement of the bone morphogenetic protein system in endothelin- and aldosterone-induced cell proliferation of pulmonary arterial smooth muscle cells isolated from human patients with pulmonary arterial hypertension. Yamanaka R; Otsuka F; Nakamura K; Yamashita M; Otani H; Takeda M; Matsumoto Y; Kusano KF; Ito H; Makino H Hypertens Res; 2010 May; 33(5):435-45. PubMed ID: 20186146 [TBL] [Abstract][Full Text] [Related]
9. Tadalafil induces antiproliferation, apoptosis, and phosphodiesterase type 5 downregulation in idiopathic pulmonary arterial hypertension in vitro. Yamamura A; Fujitomi E; Ohara N; Tsukamoto K; Sato M; Yamamura H Eur J Pharmacol; 2017 Sep; 810():44-50. PubMed ID: 28603047 [TBL] [Abstract][Full Text] [Related]
10. The Rho kinase 2 (ROCK2)-specific inhibitor KD025 ameliorates the development of pulmonary arterial hypertension. Yamamura A; Nayeem MJ; Sato M Biochem Biophys Res Commun; 2021 Jan; 534():795-801. PubMed ID: 33160621 [TBL] [Abstract][Full Text] [Related]
11. Targeting TMEM16A to reverse vasoconstriction and remodelling in idiopathic pulmonary arterial hypertension. Papp R; Nagaraj C; Zabini D; Nagy BM; Lengyel M; Skofic Maurer D; Sharma N; Egemnazarov B; Kovacs G; Kwapiszewska G; Marsh LM; Hrzenjak A; Höfler G; Didiasova M; Wygrecka M; Sievers LK; Szucs P; Enyedi P; Ghanim B; Klepetko W; Olschewski H; Olschewski A Eur Respir J; 2019 Jun; 53(6):. PubMed ID: 31023847 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of KIF23 Alleviates IPAH by Targeting Pyroptosis and Proliferation of PASMCs. Wu Z; Zhou G; Wang H; Yao P Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35457254 [TBL] [Abstract][Full Text] [Related]